Non-small cell lung cancer (NSCLC) accounts for over 80% of lung cancer cases and is often diagnosed at advanced stages, ...

Investing.com -- Aclaris Therapeutics Inc (NASDAQ: ACRS) stock surged 20% in after-hours trading following the announcement of positive top-line results from its Phase 2a trial of ATI-2138 in patients ...

Current approaches in bioengineering are synthesized and methods for their implementation are suggested for the induction and modulation of trained immunity in the treatment of human diseases.

A new study published in Current Pharmaceutical Analysis reveals that cardiolipin dysregulation may be a key factor in bortezomib-induced peripheral neuropathy (BIPN). Using lipidomics and ...

Researchers at the German Center for Cardiovascular Research (DZHK) have identified a key molecule involved in a form of ...

MicroRNA-33a and microRNA-33b are encoded within the mammalian SREBF1 and SRBF2 genes, respectively, and both SREBF1 and ...

Children who develop deep wrinkles, stunted growth, and rapidly aging bones and blood vessels as early as 1 to 2 years of age ...

New research has identified the enzyme glutamate dehydrogenase 1 (GLUD1) as a new therapeutic target for Duchenne muscular ...

New data show midkine expression is heightened in small cell lung cancer, suggesting the growth factor may be an important ...

Lu177-B7H3 monoclonal antibody is first in class targeted radiopharmaceutical in development against the 4lg subtype of B7-H3 ...

In this valuable study, the authors provide a simple yet elegant approach to identifying therapeutic targets that synergize to prevent therapeutic resistance in ovarian cancer using cell lines, ...

The development of drug delivery platforms that offer sustained release of therapeutic agents in the retina represents a ...